期刊
JOURNAL OF DERMATOLOGICAL TREATMENT
卷 20, 期 6, 页码 328-335出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/09546630902789326
关键词
Actinic keratosis; 5-fluorouracil; keratoacanthoma; psoriasis; skin cancer; topical therapy; vitiligo; warts
类别
资金
- Dermik Laboratories
Topical 5-fluorouracil (5-FU) has been used for the treatment of dermatological conditions for nearly half a century. Although the indications for 5-FU approved by the US Food and Drug Administration include actinic keratosis and superficial basal cell carcinoma, studies also have demonstrated therapeutic efficacy for 5-FU in the treatment of many other dermatological conditions, including squamous cell carcinoma in situ, warts, psoriasis of the nail, keratoacanthoma, and vitiligo. This review discusses clinical data which support the use of 5-FU for these disease states.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据